Bafna Pharmaceuticals received approval from the UK Medicines and Healthcare products Regulatory Agency (UK MHRA) for manufacturing Paracetamol Tablets and Loperamide capsules. This is the eighth formulation approval received from UK MHRA for a product by Bafna Pharma for contract manufacturing.
The approval from UK MHRA for Paracetamol and Loperamide would further help Bafna to strengthen its business in the European market. The UK MHRA approval will enable Bafna Pharma to widen the customer base in Europe. Following the recent launch of our FR&D facility in Chennai, India, we will be filing dossiers for the ever-growing UK and the European markets...................& more.
Hi fellas,
ReplyDeleteThank you so much for this wonderful article really!
If someone want to read more about that MHRA approval I think this is the right place for you!